Documents

Tiziano Barberi (PhD, senior scientist in the laboratory of Stem Cell and Tumor Biology at Memorial Sloan-Kettering Cancer Center, New York) Session: Science, Technology and Economy Round table: Open Access to Science Impact of open access in biomedical research Open access to science comes from one of the initiatives of the Open Society Institute (OSI).

Stem Cells and Public Opinion Giulio Cossu (Director, Stem Cell Research Institute Dibit, H. San Raffaele) “The experience of the Italian referendum on stem cells�? It is now approximately one year since a heated and convulse campaign on the referendum started to reach a peak of animosity and verbal violence few days before the selected

Mino Vianello Facolta’ di Statistica, ” La Sapienza” Descartes Prize E’ naturale, visto il contesto in cui nasce – contesto non solo italiano, anche se in Italia particolarmente scottante dopo l’introduzione d’una legge sulla fecondazione assistita che tocca direttamente il tema della sperimentazione con le cellule staminali embrionali – e’ naturale, dicevo, che quasi implicitamente

Speaker/Position/Organization Daniel Perry, Past President (2004-2005) and Current Vice President,Coalition for the Advancement of Medical Research (CAMR), USA – Executive Director Alliance for Aging Research Washington, DC Session: Stem Cell Science and Policies (Part I) Friday, Feb. 17, 8:30 AM Title: “Regenerative Medicine Under Attack in America: How Scientists and Patients Are Responding�? Regenerative medicine